Free Trial
NASDAQ:GERN

Geron (GERN) Stock Price, News & Analysis

Geron logo
$1.37 -0.06 (-4.20%)
Closing price 04:00 PM Eastern
Extended Trading
$1.40 +0.02 (+1.82%)
As of 06:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Geron Stock (NASDAQ:GERN)

Key Stats

Today's Range
$1.37
$1.44
50-Day Range
$1.19
$1.62
52-Week Range
$1.17
$5.06
Volume
5.94 million shs
Average Volume
11.27 million shs
Market Capitalization
$872.58 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.06
Consensus Rating
Moderate Buy

Company Overview

Geron Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
57th Percentile Overall Score

GERN MarketRank™: 

Geron scored higher than 57% of companies evaluated by MarketBeat, and ranked 432nd out of 913 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Geron has received a consensus rating of Moderate Buy. The company's average rating score is 2.78, and is based on 5 buy ratings, 3 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Geron has only been the subject of 1 research reports in the past 90 days.

  • Read more about Geron's stock forecast and price target.
  • Earnings Growth

    Earnings for Geron are expected to grow in the coming year, from ($0.25) to ($0.07) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Geron is -6.52, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Geron is -6.52, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Geron has a P/B Ratio of 2.98. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Geron's valuation and earnings.
  • Percentage of Shares Shorted

    11.06% of the float of Geron has been sold short.
  • Short Interest Ratio / Days to Cover

    Geron has a short interest ratio ("days to cover") of 5.4.
  • Change versus previous month

    Short interest in Geron has recently increased by 1.01%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Geron does not currently pay a dividend.

  • Dividend Growth

    Geron does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    11.06% of the float of Geron has been sold short.
  • Short Interest Ratio / Days to Cover

    Geron has a short interest ratio ("days to cover") of 5.4.
  • Change versus previous month

    Short interest in Geron has recently increased by 1.01%, indicating that investor sentiment is decreasing.
  • Search Interest

    Only 9 people have searched for GERN on MarketBeat in the last 30 days. This is a decrease of -31% compared to the previous 30 days.
  • MarketBeat Follows

    11 people have added Geron to their MarketBeat watchlist in the last 30 days. This is an increase of 22% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Geron insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 7.42% of the stock of Geron is held by insiders.

  • Percentage Held by Institutions

    73.71% of the stock of Geron is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Geron's insider trading history.
Receive GERN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Geron and its competitors with MarketBeat's FREE daily newsletter.

GERN Stock News Headlines

INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Geron Q1 2025: RYTELO-Wachstumspläne
Conservative Vision Of A Positive Future For Geron
See More Headlines

GERN Stock Analysis - Frequently Asked Questions

Geron's stock was trading at $3.54 at the beginning of the year. Since then, GERN stock has decreased by 61.3% and is now trading at $1.37.

Geron Corporation (NASDAQ:GERN) posted its quarterly earnings data on Wednesday, May, 7th. The biopharmaceutical company reported ($0.03) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.04) by $0.01. Geron's quarterly revenue was up 12927.3% on a year-over-year basis.
Read the conference call transcript
.

Shares of GERN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Geron investors own include Meta Platforms (META), NVIDIA (NVDA), Tesla (TSLA), Novavax (NVAX), Advanced Micro Devices (AMD), Intel (INTC) and Bristol Myers Squibb (BMY).

Company Calendar

Last Earnings
5/07/2025
Today
7/07/2025
Next Earnings (Estimated)
8/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:GERN
Employees
70
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$5.06
High Stock Price Target
$9.00
Low Stock Price Target
$1.50
Potential Upside/Downside
+255.3%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.78
Research Coverage
9 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$174.57 million
Net Margins
-119.54%
Pretax Margin
-119.54%

Debt

Sales & Book Value

Annual Sales
$76.99 million
Price / Cash Flow
N/A
Book Value
$0.46 per share
Price / Book
3.10

Miscellaneous

Free Float
589,659,000
Market Cap
$907.61 million
Optionable
Optionable
Beta
0.64

Social Links

Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

This page (NASDAQ:GERN) was last updated on 7/7/2025 by MarketBeat.com Staff
From Our Partners